Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.

Wiegand, Susanna; l'Allemand, Dagmar; Hübel, Hanna; Krude, Heiko; Bürmann, Mareike; Martus, Peter; Grüters, Annette; Holl, Reinhard W

Wiegand, Susanna; l'Allemand, Dagmar; Hübel, Hanna; Krude, Heiko; Bürmann, Mareike; Martus, Peter; Grüters, Annette; Holl, Reinhard W.

Affiliation

Wiegand S; Department of Pediatric Endocrinology and Diabetology, Charité Children's Hospital, Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, Germany. susanna.wiegand@charite.de

Eur J Endocrinol ; 163(4): 585-92, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20639355

Subject(s)

Hypoglycemic Agents/therapeutic use; Insulin/blood; Metformin/therapeutic use; Obesity/drug therapy; Placebos/therapeutic use; Adolescent; Body Mass Index; Body Weight/drug effects; Child; Female; Humans; Insulin Resistance/physiology; Male; Obesity/blood; Obesity/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placebos / Hypoglycemic Agents / Insulin / Metformin / Obesity Type of study: Clinical_trials Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2010 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google